Emergency Medicine Doctors in Stillwater, OK Accepting Medicare

6 Emergency Medicine doctors found. Showing 1 - 6

Dr. Lloyd B. Moore, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-742-5454

Dr. Charles Olson Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-742-5454

Dr. Doug N. Wilsey, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-742-5454

Dr. Marshall Scott Roach, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-742-5454

Dr. Mark R. Mueller, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-742-5454

Dr. Stuart Shoemake, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-742-5454

News Archive

BESLER Consulting expands Care Coordination and Compliance practice

BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis.

OPHN1 protein mediates mGluR-dependent longterm depression at synapses

Scientists at Cold Spring Harbor Laboratory (CSHL) have solved part of a puzzle concerning the relationship between changes in the strength of synapses - the tiny gaps across which nerve cells in the brain communicate - and dysfunctions in neural circuits that have been linked with drug addiction, mental retardation and other cognitive disorders.

European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease

Bristol-Myers Squibb announced today that BARACLUDE(R) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B in adult patients with evidence of decompensated liver disease.

Simple diagnostic imaging procedure changes treatment for lower back pain

A simple diagnostic imaging procedure can help identify patients with lower back pain who would benefit from spinal injections and spare those who would not, according to a study appearing in the February issue of Radiology.

Read more Medical News

› Verified 9 days ago